Advancing Care for Adults With Limb-Girdle Muscular Dystrophy: New Therapies and Insights

PROGRAM CHAIR

Nicholas E. Johnson, MD, MSci, FAAN
Professor and Vice Chair of Research
Director, Center for Inherited Muscle Research (CIMR)
George Bliley Research Chair
Virginia Commonwealth University
Richmond, Virginia

PROGRAM OVERVIEW

This podcast will describe the physical, emotional, social, and economic burdens associated with limb-girdle muscular dystrophy (LGMD) and its impact on caregivers, family, and healthcare systems. Additionally, it will address the rationale for genetic testing and how it contributes to the timely and accurate diagnosis of LGMD.

TARGET AUDIENCE

This activity is intended for general neurologists involved in the management of patients with LGMD.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Assess the impact of illness in adult patients with limb-girdle muscular dystrophy (LGMD).
• Promote timely and accurate diagnosis of LGMD in adults by incorporating genetic testing.

ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education (CE) for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this activity for a maximum of 0.50 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 0.50 ANCC contact hour.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an Med Learning Group–sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

All relevant financial relationships have been mitigated.

Content Review

The content of this activity was independently peer reviewed by a physician and nurse reviewer.
The reviewer(s) of this activity have nothing to disclose.

Individuals in Control of the Content of the Activity

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with commercial interests related to the content of this CME/CE activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
• John Guerriero, Vice President of Innovation and Engagement for Med Learning Group, has nothing to disclose.
• Vaidehee Deshpande, PhD, Medical Director for Med Learning Group, has nothing to disclose.
• Dominique Barton, B.S. BSN, has nothing to disclose.
• A medical reviewer from CME Peer Review LLC has nothing to disclose.
• Abigail Dill, Program Manager for Med Learning Group, has nothing to disclose.
• Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture the faculty may mention the use of medications for both US Food and Drug Administration (FDA)-approved and non-FDA-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected].

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at https://medlearninggroup.com/privacy-policy/.

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected].

Please listen to the podcast below:

RELEASED DATE: April 25, 2025
EXPIRATION DATE: April 25, 2026

Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.